bpc-157 peptide benefits risks clinical studies BPC-157: Miracle Healing or Hidden Danger? bpc-157 human clinical trials safety

Patients are encouraged to discuss any previous vitamin deficiencies, sensitivities, allergies, or recent health concerns prior to treatment

This does not mean BPC-157 raises circulating GH levels in the way GHRP peptides do

Early evidence for the potential efficacy of this route was published in 1999, where 18 patients with B12 deficiency treated exclusively with 712 days of 2 mg of sublingual cobalamin daily had 4 times higher B12 levels compared to pre-treatment, reaching therapeutic ranges ( There have also been further studies comparing treatment outcomes from the sublingual route to the more established IM and oral routes

Turn off your phone when not in use

doi: 10.1016/j.ymgme.2012.07.007